Pfizer Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $17.06B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.34B | 7.8% |
| Business Acquisitions | $241.3M | 1.4% |
| Stock Repurchases | $351.9M | 2.1% |
| Other Financing | $3.12B | 18.3% |
| Working Capital | $5.61B | 32.9% |
| Other | $6.40B | 37.5% |
| Net Cash Flow | $0 | 0.0% |